Meridian Bioscience

Meridian Bioscience is an integrated life science company. The Company is engaged in developing, manufacturing, selling, and distributing clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics, and Life Science.

Meridian Bioscience headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Medical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $540.0M in funding across 60 round(s). With a team of 501-1000 employees, Meridian Bioscience is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Meridian Bioscience, raised $2.5M. Discover more about their projects, partnerships, and impact on our platform.